InsiderClue
Stocks · Technology · Services-Prepackaged Software

BiomX Inc.

PHGE Clue Score33
United States Fiscal year ends December CIK 0001739174
Alert on the numbers Alert on insider trades

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2018Operating income−12.5Net income−12.7Fiscal year 2019Operating income−0.4Net income0.3Fiscal year 2019Operating income−22.2Net income−20.6 −6,019.0%Fiscal year 2020Operating income−30.3Net income−30.1Fiscal year 2021Operating income−35.5Net income−36.2EPS, diluted1.39Fiscal year 2022Operating income−27.2Net income−28.3EPS, diluted0.95Fiscal year 2023Operating income−25.3Net income−26.2EPS, diluted5.10Fiscal year 2024Operating income−44.5Net income−17.7EPS, diluted58.31Fiscal year 2025Operating income−41.5Net income−36.2EPS, diluted22.19
FY2018FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating income −12.5 −0.4 −22.2 −30.3 −35.5 −27.2 −25.3 −44.5 −41.5
Net income −12.7 0.3 −20.6 −30.1 −36.2 −28.3 −26.2 −17.7 −36.2
Growth −6,019.0%
EPS, diluted n/a n/a n/a n/a 1.39 0.95 5.10 58.31 22.19

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−11.3Capital expenditure−0.1Free cash flow−11.4Fiscal year 2019Operating cash flow−0.2Fiscal year 2019Operating cash flow−17.6Capital expenditure−1.3Free cash flow−18.9Fiscal year 2020Operating cash flow−24.4Capital expenditure−1.0Free cash flow−25.5Fiscal year 2021Operating cash flow−27.6Capital expenditure−3.7Free cash flow−31.3Fiscal year 2022Operating cash flow−29.1Capital expenditure−0.1Free cash flow−29.2Fiscal year 2023Operating cash flow−21.3Capital expenditure−0.1Free cash flow−21.3Fiscal year 2024Operating cash flow−37.0Capital expenditure−0.0Free cash flow−37.0Fiscal year 2025Operating cash flow−26.4Capital expenditure−0.0Free cash flow−26.4
FY2018FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −11.3 −0.2 −17.6 −24.4 −27.6 −29.1 −21.3 −37.0 −26.4
Capital expenditure −0.1 n/a −1.3 −1.0 −3.7 −0.1 −0.1 −0.0 −0.0
Free cash flow −11.4 n/a −18.9 −25.5 −31.3 −29.2 −21.3 −37.0 −26.4
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash8.6Shareholders’ equity42.8Fiscal year 2019Cash0.7Shareholders’ equity5.0Fiscal year 2019Cash72.3Shareholders’ equity84.5Fiscal year 2020Cash36.5Shareholders’ equity57.5Fiscal year 2021Cash62.1Total debt14.4Net cash (debt)47.7Shareholders’ equity47.5Debt to equity0.30Fiscal year 2022Cash31.3Total debt14.9Net cash (debt)16.5Shareholders’ equity21.0Debt to equity0.71Fiscal year 2023Cash14.9Total debt11.2Net cash (debt)3.7Shareholders’ equity3.1Debt to equity3.63Fiscal year 2024Cash16.9Shareholders’ equity24.1Fiscal year 2025Cash4.4Shareholders’ equity−1.3
FY2018FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 8.6 0.7 72.3 36.5 62.1 31.3 14.9 16.9 4.4
Total debt n/a n/a n/a n/a 14.4 14.9 11.2 n/a n/a
Net cash (debt) n/a n/a n/a n/a 47.7 16.5 3.7 n/a n/a
Shareholders’ equity 42.8 5.0 84.5 57.5 47.5 21.0 3.1 24.1 −1.3
Debt to equity n/a n/a n/a n/a 0.30 0.71 3.63 n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 30 Jun 2019 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Spending
n/a 28.0% n/a n/a n/a n/a n/a n/a n/a
Returns
−29.7% 6.9% −24.3% −52.4% −76.2% −134.6% −849.4% −73.4% n/a
−28.1% 0.5% −22.3% −42.8% −46.4% −62.2% −104.6% −41.0% −626.0%
Balance and payout
n/a n/a n/a n/a 0.30 0.71 3.63 n/a n/a
1.2% 1.2% n/a n/a n/a n/a n/a n/a 122.5%